Clin2
NCT04861051Possibly a fitRecruiting

Study ketamine effects on brain sensations in adults

Epilepsy

Treatments studied

Part of Brain & nervous system clinical trials.

This Phase 1 study tests how ketamine changes “dissociative” experiences—feelings of being disconnected from thoughts or surroundings—in adults. You may be helping researchers better understand ketamine’s effects, which could guide safer future uses.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are currently a patient in the Stanford Epilepsy Monitoring Unit
  • You are over 18 years old
  • You have never had a lifetime history of psychosis or bipolar disorder
  • You can speak, read, and understand English
  • You are not pregnant and not breastfeeding
  • You have not had a bad reaction to ketamine before

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07768618Not yet recruiting· Phase 2
How ketamine affects mood in people with epilepsy

This study gives a single low-dose ketamine infusion to people who are already staying in the hospital for epilepsy monitoring, to see if it can quickly improve mild depression symptoms. Researchers will measure brain activity to understand why ketamine helps mood.

Atlanta, Georgia
NCT05962424Recruiting· Phase 1
Study of brain activity during thinking using electrode recordings

This Phase 1 study records electrical signals from the brain while you perform thinking tasks. The goal is to better understand how human brain circuits work during cognition, and the study may help future treatments.

Palo Alto, California
NCT05019885Recruiting· Phase 2
IV ketamine for hard-to-treat epilepsy in adults

This Phase 2 study tests whether a low dose of IV ketamine can reduce seizures in adults with drug-resistant epilepsy. It may help people whose seizures continue despite trying at least two appropriate seizure medicines.

New York, New York
NCT05401227Recruiting· Phase 1
Brain scan study on glutamate and ketamine in healthy adults

This study uses a special brain scan (MRI) to understand how the brain chemical glutamate works in healthy people. You may be asked to take either an experimental drug or a placebo to see how it affects your brain chemistry.

New York, New York
NCT06788249Recruiting· Early Phase 1
Ketamine for treatment-resistant depression brain study

This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.

Philadelphia, Pennsylvania
NCT06213324Recruiting· Phase 4
Ketamine's effects on brain circuits in depression

This trial studies how ketamine affects brain circuits in people with depression compared to healthy volunteers. It involves a single infusion of ketamine and brain scans before and after.

New York, New York

Hear when a new Epilepsy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.